FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372515005: Salmeterol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197808015 Salmeterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211049017 Salmeterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1197808015 Salmeterol (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1197808015 Salmeterol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211049017 Salmeterol en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1211049017 Salmeterol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
53721000195113 salmeterolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68651000195111 Salmeterol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839271000172112 salmétérol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
839271000172112 salmétérol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
53721000195113 salmeterolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
68651000195111 Salmeterol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salmeterol (substance) Is a Substance with beta-2 adrenergic receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (substance) Is a Bronchodilator agents false Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (substance) Is a Respiratory sympathomimetic agent false Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (substance) Has disposition Beta adrenergic receptor agonist (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (substance) Has disposition Beta-2 adrenergic receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (substance) Is a Substance with phenol structure true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Salmeterol xinafoate Is a False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salmeterol adverse reaction (disorder) Causative agent (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to salmeterol (finding) Causative agent (attribute) False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol 25mcg inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol 50micrograms/blister disks+disk inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol 50micrograms/blister disks refill The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol 50micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone- and salmeterol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to salmeterol (finding) Causative agent (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salmeterol xinafoate Is modification of (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has basis of strength substance (attribute) False Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing salmeterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only fluticasone and salmeterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salmeterol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Fluticasone and salmeterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Salmeterol only product in pulmonary dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) Has basis of strength substance (attribute) True Salmeterol (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start